FABP4
Fatty acid-binding protein, adipocyte
Also known as: A-FABP, aP2, FABP4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P15090
- Gene
- FABP4
- Ensembl
- ENSG00000170323
- Chromosome
- 8
- Canonical length
- 132 aa
- Protein class
- Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
FABP4 encodes the fatty acid binding protein found in adipocytes. Fatty acid binding proteins are a family of small, highly conserved, cytoplasmic proteins that bind long-chain fatty acids and other hydrophobic ligands. It is thought that FABPs roles include fatty acid uptake, transport, and metabolism. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
132 residues, UniProt reviewed canonical sequence.
>P15090|FABP4
1 MCDAFVGTWK LVSSENFDDY MKEVGVGFAT RKVAGMAKPN MIISVNGDVI TIKSESTFKN
61 TEISFILGQE FDEVTADDRK VKSTITLDGG VLVHVQKWDG KSTTIKRKRE DDKLVVECVM
121 KGVTSTRVYE RALocalizationUniProt · AlphaFold · HPA
Whether an antibody against FABP4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 3,556 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 3,556 nTPM
- breast: 2,417 nTPM
- choroid plexus: 357 nTPM
- blood vessel: 287 nTPM
- urinary bladder: 226 nTPM
- placenta: 175 nTPM
Single-cell type
- urothelial cells: 1,744 nCPM
- vascular endothelial cells: 1,669 nCPM
- adipocytes: 1,143 nCPM
- pericytes: 1,117 nCPM
- lymphatic endothelial cells: 944 nCPM
- vascular smooth muscle cells: 342 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 72 nTPM
- thalamus: 7.2 nTPM
- hippocampal formation: 1.1 nTPM
- basal ganglia: 0.9 nTPM
- cerebral cortex: 0.8 nTPM
- cerebellum: 0.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.86
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.57
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- brown fat cell differentiation
- cellular response to lithium ion
- cellular response to tumor necrosis factor
- cholesterol homeostasis
- fatty acid transport
- long-chain fatty acid transport
- negative regulation of DNA-templated transcription
- positive regulation of cold-induced thermogenesis
- positive regulation of inflammatory response
- response to bacterium
- white fat cell differentiation
- white fat cell proliferation
Molecular functions
- fatty acid binding
- hormone receptor binding
- long-chain fatty acid binding
- long-chain fatty acid transmembrane transporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FABP4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FABP4 as an antibody target. Whether an autoantibody or antibody against FABP4 could matter depends on whether native FABP4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FABP4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FABP4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...